Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Clinical trial NCT01693068 · COMPLETED

Trial details

NCT number: NCT01693068
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Start date: 2012-12-05
Primary completion: 2015-07-04
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.